Page last updated: 2024-10-27

flumazenil and Age-Related Osteoporosis

flumazenil has been researched along with Age-Related Osteoporosis in 2 studies

Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mydlárová Blaščáková, M1
Blaščáková, Ľ1
Poráčová, J1
Mydlár, J1
Vašková, J1
Bernasovská, J1
Boroňová, I1
Petrejčíková, E1
Bernasovský, I1
Skarić-Jurić, T1
Zajc, M1
Narancić, NS1
Barbalić, M1
Salihović, MP1
Lauc, LB1

Other Studies

2 other studies available for flumazenil and Age-Related Osteoporosis

ArticleYear
Relationship between A163G osteoprotegerin gene polymorphism and other osteoporosis parameters in Roma and non-Roma postmenopausal women in eastern Slovakia.
    Journal of clinical laboratory analysis, 2017, Volume: 31, Issue:5

    Topics: Case-Control Studies; Female; Genetic Predisposition to Disease; Humans; Osteoporosis; Osteoproteger

2017
Calcaneous ultrasonographic assessment of bone mineral density in the Roma minority population of Croatia--preliminary report.
    Collegium antropologicum, 2006, Volume: 30, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone Density; Calcaneus; Croatia; Female; Humans; Male;

2006